Alvotech
Price & Volume
Stats
See moreOpen | $5.81 |
Previous Close | $5.78 |
Day Range | $5.62-$5.87 |
52W Range | $2.94-$9.04 |
Market Cap | $2B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $494.6M |
Revenue Growth (YoY) | -38.9% |
Gross Profit (12 Mos) | $300M |
Diluted EPS | -$0.62 |
News
See moreYahoo Finance • 2 months ago
Alvotech advances 18%, accelerating post-earnings rally
Yahoo Finance • 2 months ago
BofA starts bullish Alvotech coverage on biosimilar launch cycle
Yahoo Finance • 2 months ago
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
Yahoo Finance • 2 months ago
Alvotech Q2 Earnings Call Highlights
About
Address | 9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,279 |